Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, April 12, 2005 (PRIMEZONE) -- Parker & Waichman, LLP (www.yourlawyer.com) has been contacted by numerous current and former Bextra users who believe they were injured as a result of...
-
NEW YORK, April 7, 2005 (PRIMEZONE) -- Parker & Waichman, LLP commends the FDA's decision to remove Bextra from the U.S. market. In 2004, Parker & Waichman, LLP and Seeger Weiss LLP filed the...
-
NEW YORK, Dec. 10, 2004 (PRIMEZONE) -- Parker & Waichman, LLP and Seeger Weiss LLP have been retained by the family of an 83-year-old man who died as a result of Toxic Epidermal Necrolysis after...
-
NEW YORK, Nov. 23, 2004 (PRIMEZONE) -- Parker & Waichman, LLP & associated counsel continue to aggressively pursue claims on behalf of UnumProvident Corp. (NYSE:UNM) policyholders, including...
-
NEW YORK, Nov. 16, 2004 (PRIMEZONE) -- Parker & Waichman, LLP and Seeger Weiss LLP have filed a case in Supreme Court of the State of New York, County of New York against Pfizer, Inc (NYSE:PFE)....
-
GREAT NECK, N.Y., Oct. 28, 2004 (PRIMEZONE) -- Parker & Waichman, LLP: In a recent order issued by the Supreme Court, Appellate Division, 2nd Department, New York, the Court found that the Court...
-
NEW YORK , Oct. 21, 2004 (PRIMEZONE) -- Parker & Waichman, LLP is investigating claims of apparent conflicts of interest in the management of Aon Corp's (NYSE:AOC) employee retirement funds. Aon Corp...
-
NEW YORK, Oct. 21, 2004 (PRIMEZONE) -- Parker & Waichman, LLP is investigating claims of apparent conflicts of interest in the management of AON Corp's (NYSE:AOC) employee retirement funds. Aon Corp...
-
NEW YORK, Oct. 21, 2004 (PRIMEZONE) -- Parker & Waichman, LLP is reviewing claims of apparent conflicts of interest in the management of Marsh & McLennan Companies Inc. (NYSE:MMC) employee retirement...
-
NEW YORK, Oct. 1, 2004 (PRIMEZONE) -- Parker & Waichman LLP (http://www.yourlawyer.com) continues to offer free Vioxx injury case evaluations at www.vioxx-side-effects.com On Thursday, Merck & Co....